Centrus Energy holds the most advanced commercial centrifuge technology in the United States, having developed its AC100 centrifuge over the past decade at its Oak Ridge, Tennessee facility. This plant represents the only U.S. industrial-scale uranium enrichment capacity since the Cold War–era plants closed in 2013. In 2025, Centrus secured a $900 million award from the U.S. Department of Energy to expand its enrichment operations, a recognition of its role in reinforcing national energy security and reducing reliance on foreign suppliers.

For the third quarter of 2025, Centrus reported total revenue of $74.9 million, a 30% increase over the same period in 2024. Through the first nine months of 2025, revenue reached $302.5 million, up 4.1% year-over-year, while operating income surged from $2.9 million to $37.4 million, an increase of 1,189.6%. Over the past three years, the company has achieved a 20% compound annual growth rate in revenue and has bolstered its cash reserves from $671.4 million at the end of 2024 to $1.63 billion as of September 30, 2025.

Centrus ended the third quarter of fiscal 2025 with $1.63 billion in cash against $1.21 billion in debt, enabling the company to retire its debt in full and retain roughly $400 million in liquidity. The ban on Russian uranium imports, which previously accounted for 24% of U.S. utility enrichment purchases, creates sustained demand for domestic production. The U.S. Department of Energy’s goal to triple nuclear power capacity by 2050 and an expected 40% growth in global nuclear energy demand over the next 30 years underpin a long-term growth trajectory for Centrus.